Benserazide, levodopa drug combination
Showing 1 - 25 of >10,000
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Healthy Trial (single-dose madopar, single-dose propranolol, and single-dose by order, single-dose madopar, single-dose , and
Not yet recruiting
- Healthy
- single-dose madopar, single-dose propranolol, and single-dose placebo by order
- +5 more
- (no location specified)
Sep 13, 2023
Parkinson Disease Trial in Seoul (Levodopa dispersible, Levodopa)
Completed
- Parkinson Disease
- Levodopa dispersible
- Levodopa
-
Seoul, Korea, Republic of
- +1 more
May 4, 2021
Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in Sofia (Levodopa Cyclops™, INBRIJA®)
Not yet recruiting
- Parkinson
- +2 more
- Levodopa Cyclops™
- INBRIJA®
-
Sofia, BulgariaBed space for short term stay at Diagnostic & Consultative Centr
Sep 13, 2023
Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)
Recruiting
- Parkinson Disease
- Memory Impairment
- Madopar monotherapy
- +2 more
-
Beijing, ChinaPeking University Third Hospital
Jul 8, 2021
Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)
Recruiting
- Parkinson Disease
- Ongentys 50mg
- Madopar Tab. 125 or Perkin Tab. 25-100mg
-
Anyang-si, Gyeonggi-do, Korea, Republic ofHallym University Sacred Heart Hospital
Jun 17, 2021
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Diabetic Retinopathy Trial in Decatur (Sinemet CR, )
Enrolling by invitation
- Diabetic Retinopathy
- Sinemet CR
- placebo
-
Decatur, GeorgiaAtlanta VA Medical and Rehab Center, Decatur, GA
Jul 14, 2022
Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)
Withdrawn
- Stroke
- Placebo
- +2 more
-
Charlestown, MassachusettsSpaulding Rehabilitation Hospital
Dec 17, 2021
Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)
Completed
- Depression
- Levodopa+carbidopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Aug 24, 2022
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Subthalamic Deep Brain Stimulation in Advanced Parkinson's
Active, not recruiting
- Parkinson Disease
-
Helsinki, FinlandDepartment of Neurology and department of Neurosurgery Helsinki
Oct 18, 2023
Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)
Completed
- Advanced Parkinson's Disease
-
Little Rock, Arkansas
- +10 more
May 11, 2022
Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
-
Ahmedabad, Gujarat, IndiaLambda Therapeutic Research Ltd.
Nov 10, 2021
Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)
Suspended
- Depressive Disorder
- Carbidopa/levodopa
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)
Active, not recruiting
- Parkinson's Disease
- Continuous intrajejunal infusion of levodopa-carbidopa
- deep brain stimulation
-
Amsterdam, Noord Holland, NetherlandsAcademic Medical Center
Apr 20, 2022
Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)
Recruiting
- Chronic Pain
- Methylphenidate
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 9, 2023
Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Huashan Hospital
Oct 28, 2021
Levodopa-Induced Dyskinesia, Parkinson's Disease Trial in Tucson (Intervention: Ketamine)
Active, not recruiting
- Levodopa-Induced Dyskinesia
- Parkinson's Disease
- Intervention: Ketamine
-
Tucson, ArizonaScott J Sherman
Aug 27, 2023
Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,
Recruiting
- Idiopathic Parkinson's Disease
- PD patients H&Y=1.5-2 Medications ON
- +4 more
-
Pozzilli, Isernia, ItalyIRCSS Neuromed Hospital
May 18, 2022
Acute Pain, Bunionectomy, Toe Fusion Trial in Chicago (Carbidopa-Levodopa (100mg/25mg):, Naproxen)
Recruiting
- Acute Pain
- +2 more
- Carbidopa-Levodopa (100mg/25mg):
- Naproxen
-
Chicago, Illinois
- +1 more
Nov 16, 2021
AADC/TDC in Advanced Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- (no location specified)
Dec 9, 2022
Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma (MZL)
- Odronextamab
- +2 more
-
Chiang Mai, ThailandChiang Mai University
Nov 20, 2023